HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert W Tuman Selected Research

Neoplasm Metastasis (Metastasis)

11/2009JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert W Tuman Research Topics

Disease

3Neoplasms (Cancer)
11/2009 - 08/2005
1Adenocarcinoma of Lung
11/2009
1Neoplasm Metastasis (Metastasis)
11/2009
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2009
1Carcinoma (Carcinomatosis)
11/2009
1Colonic Neoplasms (Colon Cancer)
08/2005

Drug/Important Bio-Agent (IBA)

2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2009 - 12/2005
2Phosphotransferases (Kinase)IBA
11/2009 - 12/2005
2PDGF receptor tyrosine kinaseIBA
12/2005 - 08/2005
1tyrosine receptor (receptor, tyrosine)IBA
11/2009
14- cyano- N- (2- (1- cyclohexen- 1- yl)- 4- (1- ((dimethylamino)acetyl)- 4- piperidinyl)phenyl)- 1H- imidazole- 2- carboxamideIBA
11/2009
1Zoledronic Acid (Zometa)FDA Link
11/2009
1Biomarkers (Surrogate Marker)IBA
11/2009
1Macrophage Colony-Stimulating FactorIBA
11/2009
1Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA
11/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2009
1Becaplermin (PDGF-BB)FDA Link
12/2005
1Aniline CompoundsIBA
12/2005
1AntibodiesIBA
08/2005
1(6,7- dimethoxy- 2,4- dihydroindeno(1,2- c)pyrazol- 3- yl)(3- fluorophenyl)amineIBA
08/2005
1Phospholipases (Phospholipase)IBA
08/2005